EUCTR2005-002042-19-ES进行中（未招募）不适用
Double-blind, placebo controlled cross-over study to assess the efficacy of Levetiracetam in paediatric and childhood non-epileptic myoclonusEstudio cruzado, aleatorizado, doble ciego controlado con placebo, para evaluar la eficacia del Levetiracetam en el tratamiento del mioclonus no epiléctico en pacientes pediátricos y adolescentes
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •·Aged between 6 and 18 years.
- •·Myoclonus is the sole or primary neurological abnormality.
- •·Confirmed diagnosis (by EEG or EMG) of primary non-epileptic myoclonus ( myoclonus-dystonia, essential myoclonus, hyperekplexia, etc.) or secondary non-epileptic myoclonus.
- •·Duration of the disorder of more than 1 year.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years)
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •·Patients with any of the conditions above mentioned but with a transient (duration less a year) occurrence.
- •·Patients who are expected to move from Catalonia in the next two years.
- •·Patients with dyskinetic cerebral palsy
研究者
相似试验
进行中（未招募）
不适用
Double-blind, placebo controlled cross-over study to assess efficacy of Levetiracetam in paediatric and childhood Tourette syndrome. Estudio cruzado, aleatorizado, doble ciego controlado con placebo, para evaluar la eficacia del Levetiracetam en el control de los tics de pacientes pediátricos y adolescentes con síndrome de Gilles de la TouretteTourette syndromeEUCTR2005-002041-40-ESHospital Sant Joan de Déu
进行中（未招募）
不适用
Mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosaCongenital disorders of the skin, recessive dystrophic epidermolysis bullosaSkin and Connective Tissue DiseasesEpidermolysis bullosa dystrophicaISRCTN14409785Great Ormond Street Hospital for Children NHS Foundation Trust36
已完成
不适用
Double blind, placebo controlled crossover study of the efficacy and side effects of low dose amitriptyline treatment for chronic pain, disordered sleep and reduced mobility in children with Epidermolysis BullosaEpidermolysis bullosaISRCTN81030001niversity College London (UCL) Institute of Child Health (UK)40
进行中（未招募）
1 期
A double-blind placebo controlled cross-over study to determine if 1.5 and 3mg of APL510 can normalise sleep patterns in elderly subjects with difficulty in maintenance of sleep and/or initiating sleep onset. - N/AEUCTR2004-003939-32-GBAlliance Pharmaceuticals Ltd80
进行中（未招募）
1 期
Double-blind,placebo-controlled cross-over study for evaluation of the efficacy of the PDE-5-inhibitor vardenafil on the peripheral perfusion and the clinical symptomatology of patients with Raynaud´s disease.Raynaud´s disease (RD) is defined as episodic, painful, cold- or emotional stress-triggered vasospasms of the digital arteries and precapillary arterioles for up to 30 minutes with or without underlying disease, leading to ischemia of the fingersEUCTR2005-000295-41-DEniversität zu Köln57